Keynote Opening: Life lessons on how to build a career and leave a legacy.
30 May 2024 - Utrecht
Martine van Vugt | EVP & CSO | Genmab
Martine van Vugt is a senior executive with 20 years of
biotechnology industry experience. A proven leader with successful track record
of leading high performing global cross functional teams in a networked biotech
environment. She is skilled in developing joint business value propositions,
designing relationship structures and management of alliances. An Expert in
corporate transactional and licensing operations, such as strategic partnering,
in- and out-licensing, as well as asset divestment and purchases. She effectively
blends analytical skills with a natural leadership style grounded in science
and integrity. As Genmab’s EVP & Chief
Strategy Officer, Martine leads the Corporate Strategy, Corporate Development & Business Development and
Licensing as well as Alliance Management functions and manages the
strategic agenda of the senior leadership team. Martine holds a board positions
at I Scandion Oncology.
Martine van Vugt | EVP & CSO | Genmab
Martine van Vugt is a senior executive with 20 years of
biotechnology industry experience. A proven leader with successful track record
of leading high performing global cross functional teams in a networked biotech
environment. She is skilled in developing joint business value propositions,
designing relationship structures and management of alliances. An Expert in
corporate transactional and licensing operations, such as strategic partnering,
in- and out-licensing, as well as asset divestment and purchases. She effectively
blends analytical skills with a natural leadership style grounded in science
and integrity. As Genmab’s EVP & Chief
Strategy Officer, Martine leads the Corporate Strategy, Corporate Development & Business Development and
Licensing as well as Alliance Management functions and manages the
strategic agenda of the senior leadership team. Martine holds a board positions
at I Scandion Oncology.
About Genmab
Genmab is an international biotechnology company with a core
purpose guiding its unstoppable team to strive towards improving the lives of
patients through innovative and differentiated antibody therapeutics. For more
than 20 years, its passionate, innovative and collaborative team has invented
next generation antibody technology platforms and leveraged translational
research and data sciences, which has resulted in a proprietary pipeline
including bispecific T-cell engagers, next-generation immune checkpoint modulators,
effector function enhanced antibodies and antibody-drug conjugates. To help
develop and deliver novel antibody therapies to patients, Genmab has formed 20+
strategic partnerships with biotechnology and pharmaceutical companies. By
2030, Genmab’s vision is to transform the lives of people with cancer and other
serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with
locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo,
Japan. For more information, please visit Genmab.com and follow us on
X.com/Genmab.
About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com and follow us on X.com/Genmab.
| For job seekers | For employers | Join BCF Career Event |
| | Register BCF NL | |
| Powered by: Hyphen Projects Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 |
© Copyright 2024 by Hyphen Projects